What are Factor XIa inhibitor drugs?

Factor XIa inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting Factor XIa). 0 are currently marketed, with 3 more in clinical development.

Factor XIa inhibitor

0 marketed 3 in Phase 3

This page covers all Factor XIa inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Factor XIa.

Targets

Factor XIa

Phase 3 pipeline (3)

KHK7791 · Kyowa Kirin Co., Ltd. · Cardiovascular
KHK7791 is a Factor XIa inhibitor that reduces thrombin generation by blocking a key coagulation cascade enzyme, thereby reducing thrombotic risk.
KHK4827 · Kyowa Kirin Co., Ltd. · Cardiovascular
KHK4827 is a Factor XIa inhibitor that reduces thrombin generation by blocking a key enzyme in the intrinsic coagulation pathway.
KHK7580 · Kyowa Kirin Co., Ltd. · Cardiovascular
KHK7580 is a Factor XIa inhibitor that reduces thrombin generation by blocking a key enzyme in the intrinsic coagulation pathway.